ClinicalTrials.Veeva

Menu

Growth of Infants Fed Hydrolysate Formulas

Abbott logo

Abbott

Status

Completed

Conditions

Growth and Tolerance

Treatments

Other: Powder Infant Formula
Other: RTF Infant Formula

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.

Enrollment

195 patients

Sex

All

Ages

Under 9 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Infants in good health.
  • Singleton, term birth with a gestational age of 37 to 42 weeks.
  • Birth weight of 2500 g (5 lb 8 oz) or greater.
  • Between 0 and 9 days of age at enrollment.
  • Not receiving vitamin or mineral supplements.

Exclusion criteria

  • Maternal, fetal or perinatal medical history with potential for adverse effects on growth or development.

Trial design

195 participants in 2 patient groups

RTF Infant Formula 1
Active Comparator group
Description:
a ready to feed (RTF) extensively hydrolyzed infant formula fed ad lib.
Treatment:
Other: RTF Infant Formula
Powder Infant Formula 2
Experimental group
Description:
a powdered extensively hydrolyzed infant formula fed ad lib.
Treatment:
Other: Powder Infant Formula

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems